Cancer Prevention and Control Recent Publications

• Smartband-based smoking detection and real-time brief mindfulness intervention: findings from a feasibility clinical trial.Horvath M, Pittman B, O'Malley SS, Grutman A, Khan N, Gueorguieva R, Brewer JA, Garrison KA. Ann Med. 2024 Dec; 2024 Jun 1. PMID: 38823419.
• A gap analysis of UK biobank publications reveals SNPs associated with intrinsic subtypes of breast cancer.van den Driest L, Kelly P, Marshall A, Johnson CH, Lasky-Su J, Lannigan A, Rattray Z, Rattray NJW. Comput Struct Biotechnol J. 2024 Dec; 2024 May 10. PMID: 38817965.
• Development and initial testing of mindful journey: a digital mindfulness-based intervention for promoting recovery from Substance use disorder.Roos CR, Kiluk B, Carroll KM, Bricker JB, Mun CJ, Sala M, Kirouac M, Stein E, John M, Palmer R, DeBenedictis A, Frisbie J, Haeny AM, Barry D, Fucito LM, Bowen S, Witkiewitz K, Kober H. Ann Med. 2024 Dec; 2024 Feb 21. PMID: 38382111.
• Peripheral blood immune parameters, response, and adverse events after neoadjuvant chemotherapy plus durvalumab in early-stage triple-negative breast cancer.Foldi J, Blenman KRM, Marczyk M, Gunasekharan V, Polanska A, Gee R, Davis M, Kahn AM, Silber A, Pusztai L. Breast Cancer Res Treat. 2024 Nov; 2024 Jul 13. PMID: 39002068.
• Reply.Schmitz KH, Brown JC, Irwin ML, Robien K, Scott JM, Perna FM. J Natl Cancer Inst. 2024 Oct 9; 2024 Oct 9. PMID: 39383207.
• Social Support and Psychological Capital Mediate the Effect of Personalities on the Mental Health of Professional Staff in China During COVID-19 Pandemic.Yao Y, Tang J, Li Z, Chen S, Du H, Lu L. Psychol Res Behav Manag. 2024; 2024 Oct 5. PMID: 39385810.
• Diagnostic experiences of Black and White patients with uterine cancer: A qualitative study.Britton MC, Izampuye E, Clark M, Ornstein RA, Nunez-Smith M, Wright JD, Xu X. Gynecol Oncol. 2024 Oct 2; 2024 Oct 2. PMID: 39362045.
• USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years.Siddique S, Wang R, Yasin F, Gaddy JJ, Zhang L, Gross CP, Ma X. JAMA Netw Open. 2024 Oct 1; 2024 Oct 1. PMID: 39361285.
• Cardiomyopathy-Associated Chronic Heart Failure in Infants Aged <1 Year: A Prospective Observational Cohort Over 5 Years in Northern China.Ding W, Wang B, Hong J, Lu L, Xiao Y, Shan G, Myers C, Yu Q, Spurney C, Li Z, Han L. J Am Heart Assoc. 2024 Oct; 2024 Sep 30. PMID: 39344650.
• Associations Between Reductions in Depressive Symptoms and Reductions in Pain and Anxiety Symptoms and Substance Use: Emulation of a Randomized Trial.Khan MR, Acri M, Ban KF, Scheidell JD, Stevens ER, Manandhar-Sasaki P, Charles D, Chichetto NE, Crystal S, Gordon AJ, Marshall BDL, Edelman EJ, Justice AC, Braithwaite SR, Caniglia EC. AJPM Focus. 2024 Oct; 2024 Jul 6. PMID: 39290574.
• Barriers to Effective Infection Prevention in the Neonatal Intensive Care Unit: A Qualitative Study.Weser VU, Crocker A, Murray TS, Wright J, Truesdell EJK, Ciaburri R, Marks AM, Martinello RA, Hieftje KD. Adv Neonatal Care. 2024 Oct 1; 2024 Aug 27. PMID: 39196970.
• Evaluating Supplemental Breast Cancer Screening With Simulation Modeling.Richman IB, Battaglia TA. JAMA Intern Med. 2024 Oct 1. PMID: 39186297.
• Patterns of Physical Therapy Referral and Subsequent Attendance Among Childhood Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy at a Regional Childhood Cancer Survivorship Clinic.Kang L, Kadan-Lottick NS, Rotatori J, Kujawski SE, Messerschmidt E, Auerbach C, Balsamo LM, Lustberg MB, Ma X, Rodwin RL. Semin Oncol Nurs. 2024 Oct; 2024 Aug 19. PMID: 39164160.
• The combination of donepezil and cognitive training for improving treatment outcomes for alcohol use disorder: Design of a randomized controlled trial.Yoon G, Sofuoglu M, Petrakis IL, Pittman B, Bell MD. Contemp Clin Trials. 2024 Oct; 2024 Aug 5. PMID: 39111388.
• Design and methods of the StepByStep randomized trial of a mobile health and social media physical activity intervention among adolescent and young adult survivors of childhood cancer: A report from the Children's Oncology Group.Beight LJ, Mendoza JA, Leisenring WM, Collier W, Olsen ME, Ross WL, Santiago-Rivera Y, Bryant S, Rotatori J, Ness KK, Hurtado-de-Mendoza A, Baker KS, Chow EJ, Kadan-Lottick NS. Contemp Clin Trials. 2024 Oct; 2024 Jul 28. PMID: 39079612.
• Keeping Race and Diversity Relevant in Medical Education.Baugh AD, Akgün KM, Rusk A, Adelson VA, Afolabi F, Crowder S, Ferreira JC, Gurubhagavatula I, Lovinsky-Desir S, Lawrence K, Myers LC, Niranjan SJ, Schotland H, Sheares BJ, Sullivan DR, Wisnivesky J, Sweet SC. Ann Am Thorac Soc. 2024 Oct. PMID: 39078251.
• Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton's tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline setting.Huntington SF, Manzoor BS, Jawaid D, Puckett JT, Emechebe N, Ravelo A, Kamal-Bahl S, Doshi JA. J Manag Care Spec Pharm. 2024 Oct; 2024 Jul 24. PMID: 39046941.
• Real-World Treatment Patterns, Survival, and Economic Burden Among Elderly MCL Patients Previously Treated With cBTKis.Squires P, Puckett J, Ryland KE, Kamal-Bahl S, Raut M, Doshi J, Huntington SF. Clin Lymphoma Myeloma Leuk. 2024 Oct; 2024 Jun 4. PMID: 39034204.
• Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma.McNamara B, Greenman M, Bellone S, Santin LA, Demirkiran C, Mutlu L, Hartwich TMP, Yang-Hartwich Y, Ratner E, Schwartz PE, Santin AD. Gynecol Oncol. 2024 Oct; 2024 Jul 8. PMID: 38981151.
• Changes in Facility Share of Medicaid-insured Patients With Urologic Cancers Following Implementation of the Patient Protection and Affordable Care Act.Demkowicz PC, Buck MB, Nie J, Marks VA, Wheeler SB, Dinan MA, Gross CP, Leapman MS. Urology. 2024 Oct; 2024 Jun 18. PMID: 38901803.
• Risk Factors and Contemporary Management Options for Pain and Discomfort Experienced During a Prostate Biopsy.Diaz GM, Webb LT, Rabil MJ, Lokeshwar SD, Choksi AU, Leapman MS, Sprenkle PC. Curr Urol Rep. 2024 Oct; 2024 Jun 19. PMID: 38896314.
• Characterization of time toxicity in older patients with metastatic breast cancer.Atre SY, Soulos PR, Kuderer NM, Gross CP, Baum LVM, Dinan MA, Lustberg MB. Breast Cancer Res Treat. 2024 Oct; 2024 May 31. PMID: 38816556.
• Predisposing, Enabling, and Need Factors Driving Palliative Care Use in Head and Neck Cancer.Fereydooni S, Valdez C, William L, Malik D, Mehra S, Judson B. Otolaryngol Head Neck Surg. 2024 Oct; 2024 May 26. PMID: 38796734.
• Trends in breast cancer specific death by clinical stage at diagnoses between 2000-2017.Marczyk M, Kahn A, Silber A, Rosenblit M, Digiovanna MP, Lustberg M, Pusztai L. J Natl Cancer Inst. 2024 Sep 30; 2024 Sep 30. PMID: 39348186.
• Charting the metabolic biogeography of the colorectum in cancer: challenging the right sided versus left sided classification.Jain A, Morris MT, Berardi D, Arora T, Domingo-Almenara X, Paty PB, Rattray NJW, Kerekes D, Lu L, Khan SA, Johnson CH. Mol Cancer. 2024 Sep 28; 2024 Sep 28. PMID: 39342363.
• Editorial for the themed issue: Addressing the dual challenges of opioid use disorder and chronic pain in the context of the opioid crisis.Sofuoglu M, MacLean RR, De Aquino JP. Br J Clin Pharmacol. 2024 Sep 27; 2024 Sep 27. PMID: 39340184.
• Sociodemographic disparities in prostate cancer imaging.Sundaresan V, Lokeshwar S, Sutherland R, Sohoni N, Golos A, Ajjawi I, Leapman M. Abdom Radiol (NY). 2024 Sep 26; 2024 Sep 26. PMID: 39325212.
• Integrated stepped alcohol treatment with contingency management for unhealthy alcohol use among people with HIV: A randomized controlled trial.Edelman EJ, Dziura J, Deng Y, DePhilippis D, Ferguson T, Brown S, Marconi VC, Goetz MB, Rodriguez-Barradas MC, Simberkoff MS, Molina PE, Weintrob AC, Maisto SA, Paris M, Justice AC, Bryant KJ, Fiellin DA. J Acquir Immune Defic Syndr. 2024 Sep 25; 2024 Sep 25. PMID: 39321757.
• Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of youth and adults in the PATH Study in 2015-2017 vs 2017-2019.Brouwer AF, Jeon J, Jimenez-Mendoza E, Land SR, Holford TR, Friedman AS, Tam J, Mistry R, Levy DT, Meza R. Tob Control. 2024 Sep 25; 2024 Sep 25. PMID: 36977570.
• Barriers to the Uptake of Tickborne Disease Prevention Measures: Connecticut, Maryland 2016-2017.Hansen AP, Wilkinson MM, Niesobecki S, Rutz H, Meek JI, Niccolai L, Hinckley AF, Hook S. J Public Health Manag Pract. 2024 Sep 24; 2024 Sep 24. PMID: 39321400.
• Use of cannabis among youth who vape nicotine.Davis DR, Bold KW, Wu R, Morean ME, Kong G, Krishnan-Sarin S. Addict Behav. 2024 Sep 22; 2024 Sep 22. PMID: 39326231.
• Accessing breast cancer care in a protracted conflict: Qualitative exploration of the perspectives of women with breast cancer in northwest Syria.Marzouk M, Hamze M, Debel J, Alshemali A, Alameen BA, Bakkour M, Galal B, Chagpar AB, Atassi B, Khoshnood K, Abbara A. Soc Sci Med. 2024 Sep 21; 2024 Sep 21. PMID: 39357306.
• Understanding Barriers and Facilitators to Disaster Preparedness in Federally Qualified Health Centers in the United States: A Mixed Methods Study.Hassan S, Wiciak M, Escobar K, González Montalvo MDM, Richards T, Villanueva H, Ortiz J, Evans DP, Nunez-Smith M. Disaster Med Public Health Prep. 2024 Sep 18; 2024 Sep 18. PMID: 39291834.
• Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN. BMC Public Health. 2024 Sep 18; 2024 Sep 18. PMID: 39289635.
• Strength of Evidence Underlying the CMS-FDA Parallel Review of Comprehensive Genomic Profiling Tests in the Cancer Setting.Stackland S, Schnabel D, Dinan M, Presley CJ, Gross CP. J Natl Cancer Inst. 2024 Sep 18; 2024 Sep 18. PMID: 39288939.
• Building Frontline Capability for Shared Decision-Making (SDM) in a Major Academic Oncology Center Caring for People With Non-Small Cell Lung Cancer: Performance Outcomes of a SDM Simulation Training Program.Alexander CC, Hakim H, Rudell E, Ingram M, Agrawal T, Peterson P, Davies M, Adelson K, Oliver BJ. Perm J. 2024 Sep 16; 2024 Sep 13. PMID: 39269220.
• A Qualitative Study on the Impact and Feasibility of a Simulation-Based Program for Shared Decision-Making in Non-Small Cell Lung Cancer Care.Hakim H, Alexander CC, Rudell E, Ingram M, Agrawal T, Peterson P, Davies M, Adelson K, Oliver BJ. Perm J. 2024 Sep 16; 2024 Sep 13. PMID: 39269215.
• Correlates of improved outcomes in patients with COVID-19 treated in US emergency departments.Slutske WS, Kirsch JM, Piasecki TM, Conner KL, Williams B, Fiore MC, Bernstein SL. Am J Emerg Med. 2024 Sep 14; 2024 Sep 14. PMID: 39305696.
• Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Shatsky RA, Trivedi MS, Yau C, Nanda R, Rugo HS, Davidian M, Tsiatis B, Wallace AM, Chien AJ, Stringer-Reasor E, Boughey JC, Omene C, Rozenblit M, Kalinsky K, Elias AD, Vaklavas C, Beckwith H, Williams N, Arora M, Nangia C, Roussos Torres ET, Thomas B, Albain KS, Clark AS, Falkson C, Hershman DL, Isaacs C, Thomas A, Tseng J, Sanford A, Yeung K, Boles S, Chen YY, Huppert L, Jahan N, Parker C, Giridhar K, Howard FM, Blackwood MM, Sanft T, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Symmans WF, Price E, Heditsian D, LeStage B, Perlmutter J, Pohlmann P, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. Nat Med. 2024 Sep 14; 2024 Sep 14. PMID: 39277672.
• Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Khoury K, Meisel JL, Yau C, Rugo HS, Nanda R, Davidian M, Tsiatis B, Chien AJ, Wallace AM, Arora M, Rozenblit M, Hershman DL, Zimmer A, Clark AS, Beckwith H, Elias AD, Stringer-Reasor E, Boughey JC, Nangia C, Vaklavas C, Omene C, Albain KS, Kalinsky KM, Isaacs C, Tseng J, Roussos Torres ET, Thomas B, Thomas A, Sanford A, Balassanian R, Ewing C, Yeung K, Sauder C, Sanft T, Pusztai L, Trivedi MS, Outhaythip A, Li W, Onishi N, Asare AL, Beineke P, Norwood P, Brown-Swigart L, Hirst GL, Matthews JB, Moore B, Fraser Symmans W, Price E, Beedle C, Perlmutter J, Pohlmann P, Shatsky RA, DeMichele A, Yee D, van 't Veer LJ, Hylton NM, Esserman LJ. Nat Med. 2024 Sep 14; 2024 Sep 14. PMID: 39277671.
• Real-World Effectiveness of Nirsevimab Against Respiratory Syncytial Virus: A Test-Negative Case-Control Study.Xu H, Aparicio C, Wats A, Araujo BL, Pitzer VE, Warren JL, Shapiro ED, Niccolai LM, Weinberger DM, Oliveira CR. medRxiv. 2024 Sep 12; 2024 Sep 12. PMID: 39314944.
• Tubal Sterilization Rates by State Abortion Laws After the Dobbs Decision.Xu X, Chen L, Desai VB, Gross CP, Pollack CE, Schwartz PE, Wright JD. JAMA. 2024 Sep 11; 2024 Sep 11. PMID: 39259564.
• Real World Data on Efficacy and Safety of EPOCH in T-Cell Lymphoma.Straining R, Foss F, Schiffer M, Amin K, Agarwal S, Isufi I, Huntington S, Kothari S, Seropian S, Girardi M, Sethi T. Clin Lymphoma Myeloma Leuk. 2024 Sep 8; 2024 Sep 8. PMID: 39368885.
• Barriers and facilitators for implementing the WHO Safe Childbirth Checklist (SCC) in Mozambique: A qualitative study using the Consolidated Framework for Implementation Research (CFIR).He A, Kanduma EL, Pérez-Escamilla R, Buckshee D, Chaquisse E, Cuco RM, Desai MM, Munguambe D, Reames SE, Manuel IR, Spiegelman D, Xu D. PLOS Glob Public Health. 2024; 2024 Sep 5. PMID: 39236014.
• Understanding risk factors for endometrial cancer in young women.Peeri NC, Bertrand KA, Na R, De Vivo I, Setiawan VW, Seshan VE, Alemany L, Chen Y, Clarke MA, Clendenen T, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, Gierach GL, Goodman MT, La Vecchia C, Levi F, Lopez-Querol M, Lu L, Moysich KB, Mutter G, Naduparambil J, Negri E, O'Connell K, O'Mara T, Palmer JR, Parazzini F, Penney KL, Petruzella S, Reynolds P, Ricceri F, Risch H, Rohan TE, Sacerdote C, Sandin S, Shu XO, Stolzenberg-Solomon RZ, Webb PM, Wentzensen N, Wilkens LR, Xu W, Yu H, Zeleniuch-Jacquotte A, Zheng W, Guo X, Lipworth L, Du M. J Natl Cancer Inst. 2024 Sep 5; 2024 Sep 5. PMID: 39235934.
• A Digital Cognitive Behavioral Therapy Program for Adults With Alcohol Use Disorder: A Randomized Clinical Trial.Kiluk BD, Benitez B, DeVito EE, Frankforter TL, LaPaglia DM, O'Malley SS, Nich C. JAMA Netw Open. 2024 Sep 3; 2024 Sep 3. PMID: 39325452.
• Reprint of: Sex differences in appeal, reward, and sensory experience of E-cigarette flavors among adults who smoke cigarettes.Davis DR, Buta E, Green B, Krishnan-Sarin S. Prev Med. 2024 Sep 3; 2024 Sep 3. PMID: 39232940.
• Exposure range matters: considering non-linear associations in the meta-analysis of environmental pollutant exposure using examples of per- and polyfluoroalkyl substances and birth outcomes.Guo P, Warren JL, Deziel NC, Liew Z. Am J Epidemiol. 2024 Sep 3; 2024 Sep 3. PMID: 39227151.
• Variability in Constituents of E-Cigarette Products Containing Nicotine Analogues.Erythropel HC, Jabba SV, Silinski P, Anastas PT, Krishnan-Sarin S, Zimmerman JB, Jordt SE. JAMA. 2024 Sep 3. PMID: 39110443.
• Folate Metabolism and Risk of Childhood Acute Lymphoblastic Leukemia: A Genetic Pathway Analysis from the Childhood Cancer and Leukemia International Consortium.Metayer C, Spector LG, Scheurer ME, Jeon S, Scott RJ, Takagi M, Clavel J, Manabe A, Ma X, Hailu EM, Lupo PJ, Urayama KY, Bonaventure A, Kato M, Meirhaeghe A, Chiang CWK, Morimoto LM, Wiemels JL. Cancer Epidemiol Biomarkers Prev. 2024 Sep 3. PMID: 38904462.
• Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk.Ni Z, Kundu P, McKean DF, Wheeler W, Albanes D, Andreotti G, Antwi SO, Arslan AA, Bamlet WR, Beane-Freeman LE, Berndt SI, Bracci PM, Brennan P, Buring JE, Chanock SJ, Gallinger S, Gaziano JM, Giles GG, Giovannucci EL, Goggins MG, Goodman PJ, Haiman CA, Hassan MM, Holly EA, Hung RJ, Katzke V, Kooperberg C, Kraft P, LeMarchand L, Li D, McCullough ML, Milne RL, Moore SC, Neale RE, Oberg AL, Patel AV, Peters U, Rabe KG, Risch HA, Shu XO, Smith-Byrne K, Visvanathan K, Wactawski-Wende J, White E, Wolpin BM, Yu H, Zeleniuch-Jacquotte A, Zheng W, Zhong J, Amundadottir LT, Stolzenberg-Solomon RZ, Klein AP. Cancer Epidemiol Biomarkers Prev. 2024 Sep 3. PMID: 38869494.
• Telomere transcripts act as tumor suppressor and are associated with favorable prognosis in colorectal cancer with low proliferating cell nuclear antigen expression.Kienzl P, Deloria AJ, Hunjadi M, Hadolt JM, Haering MF, Bothien A, Mejri D, Korkut-Demirbaş M, Sampl S, Weber G, Pirker C, Laengle S, Braunschmid T, Dragona E, Marian B, Gagos S, Lu L, Henson JD, Lau LMS, Reddel RR, Mikulits W, Stättner S, Holzmann K. Cell Oncol (Dordr). 2024 Sep 2; 2024 Sep 2. PMID: 39222177.
• Cost trends of metastatic renal cell carcinoma therapy: the impact of oral anticancer agents and immunotherapy.Forman R, Long JB, Westvold SJ, Agnish K, Mcmanus HD, Leapman MS, Hurwitz ME, Spees LP, Wheeler SB, Gross CP, Dinan MA. JNCI Cancer Spectr. 2024 Sep 2. PMID: 39133171.
• A Brief Report of Lung Cancer Screening Utilization Before, During, and in the Later Stages of the COVID-19 Pandemic in the United States.Poghosyan H, Sarkar S, Richman I, Pietrzak RH, Carter-Bawa L, Cooley ME. JTO Clin Res Rep. 2024 Sep; 2024 Jul 6. PMID: 39282662.
• Laryngeal rare benign non-epithelial tumors and sarcomas emphasizing on chondrosarcomas: A literature review and a case presentation.Vageli DP, Doukas PG, Paraskeva AN, Zacharouli K, Judson BL, Ioannou M. Pathol Res Pract. 2024 Sep; 2024 Jul 30. PMID: 39116572.
• Psychometric evaluation of the Self-Report Habit Index for assessing habitual e-cigarette use behavior in high school adolescents.Morean ME, Davis DR, Kong G, Bold KW, Talley A, Krishnan-Sarin S. Drug Alcohol Depend Rep. 2024 Sep; 2024 Jun 28. PMID: 39050698.
• Randomized Clinical Trials That Advance Health and Health Equity: JAMA Internal Medicine Call for Papers.Wang TY, Corbie G, Allore HG, Anderson TS, Durant R, Ganguli I, Grady D, Gross CP, Katz M, Mody L, Tripodis Y, Inouye SK. JAMA Intern Med. 2024 Sep 1. PMID: 39008289.
• A preliminary investigation of the acute effects of delta-9-tetrahydrocannabinol on pain and opioid attentional bias among persons with opioid use disorder.Wolkowicz NR, Sofuoglu M, Pittman B, Meyerovich J, MacLean RR, De Aquino JP. J Psychiatr Res. 2024 Sep; 2024 Jun 27. PMID: 38991269.
• Residential Proximity to Oil and Gas Development and Mental Health in a North American Preconception Cohort Study: 2013-2023.Willis MD, Campbell EJ, Selbe S, Koenig MR, Gradus JL, Nillni YI, Casey JA, Deziel NC, Hatch EE, Wesselink AK, Wise LA. Am J Public Health. 2024 Sep; 2024 Jul 11. PMID: 38991173.
• Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans.Parida S, MacLean RR, Gueorguieva R, Sofuoglu M. Psychopharmacology (Berl). 2024 Sep; 2024 Jul 6. PMID: 38970644.
• Association of Medical School Gap Year Research and Degree Programs With Otolaryngology Interview and Match Outcomes.Boyi T, Benjamin WJ, Lenze NR, Brenner MJ, Mihalic AP, Kupfer RA, Judson BL, Lee YH. Ann Otol Rhinol Laryngol. 2024 Sep; 2024 Jun 17. PMID: 38887016.
• Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive, Early-Stage Breast Cancer.Chavez-MacGregor M, Miao J, Pusztai L, Goetz MP, Rastogi P, Ganz PA, Mamounas EP, Paik S, Bandos H, Razaq W, O'Dea A, Kaklamani V, Silber ALM, Flaum LE, Andreopoulou E, Wendt AG, Carney JF, Sharma P, Gralow JR, Lew DL, Barlow WE, Hortobagyi GN. J Clin Oncol. 2024 Sep 1; 2024 Jun 4. PMID: 38833643.
• Plant-based diets, animal agriculture, and the connection with urological and planetary health.Gupta N, Leapman MS, Loeb S. Curr Opin Urol. 2024 Sep 1; 2024 May 31. PMID: 38832408.
• Reply to Editorial Comment on "Association of Crowd-Sourced Assessment of Technical Skills and Outcomes of Robotic-assisted Radical Prostatectomy".Rabil MJ, Leapman MS, Cavallo JA. Urology. 2024 Aug 28; 2024 Aug 28. PMID: 39208938.
• Peripheral Arterial Disease prevalence and risk factors in the Eastern Caribbean Health Outcomes Research Network (ECHORN) cohort.Adams OP, Galusha D, Martinez-Brockman JL, Morris EH, Hassan S, Maharaj RG, Nazario CM, Nunez M, Nunez-Smith M. PLoS One. 2024; 2024 Aug 26. PMID: 39186495.
• Changing patterns of cigarette and ENDS transitions in the USA: a multistate transition analysis of adults in the PATH Study in 2017-2019 vs 2019-2021.Brouwer AF, Jeon J, Jimenez-Mendoza E, Land SR, Holford TR, Friedman AS, Tam J, Mistry R, Levy DT, Meza R. Tob Control. 2024 Aug 22; 2024 Aug 22. PMID: 39174323.
• Words matter: descriptors for nicotine that comes from tobacco and descriptors for synthetic nicotine that is created in a laboratory differentially impact understanding of nicotine source and risk perceptions.Morean ME, O'Malley SS, Krishnan-Sarin S. Tob Control. 2024 Aug 21; 2024 Aug 21. PMID: 39168594.
• Sex differences in comorbid pain and opioid use disorder: A scoping review.DeVito EE, Ameral V, Sofuoglu M. Br J Clin Pharmacol. 2024 Aug 21; 2024 Aug 21. PMID: 39168150.
• Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).Nowak JA, Twombly T, Ma C, Shi Q, Haruki K, Fujiyoshi K, Väyrynen J, Zhao M, Knight J, Mane S, Shergill A, Kumar P, Couture F, Kuebler P, Krishnamurthi S, Tan B, Philip P, O'Reilly EM, Shields AF, Ogino S, Fuchs CS, Meyerhardt JA. J Clin Oncol. 2024 Aug 20; 2024 Jun 18. PMID: 38889377.
• Transacylation and hydrolysis of the acyl glucuronides of ibuprofen and its α-methyl-substituted analogues investigated by (1)H NMR spectroscopy and computational chemistry: Implications for drug design.Richards SE, Bradshaw PR, Johnson CH, Stachulski AV, Athersuch TJ, Nicholson JK, Lindon JC, Wilson ID. J Pharm Biomed Anal. 2024 Aug 15; 2024 May 20. PMID: 38805849.
• Barriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study.Puklin LS, Irwin ML, Sanft T, Ferrucci LM, Harrigan M, McGowan C, Cartmel B, Zupa M, Winer EP, Deyling M, Ligibel JA, Basen-Engquist K, Spiegelman D, Sharifi M. Support Care Cancer. 2024 Aug 14; 2024 Aug 14. PMID: 39141176.
• Parent-Clinician Communication and Prolonged Grief in Parents Whose Child Died From Cancer.Ouyang N, Baker JN, Ananth PJ, Knobf MT, Snaman JM, Feder SL. J Pain Symptom Manage. 2024 Aug 12; 2024 Aug 12. PMID: 39142495.
• Human AKR1C3 binds agonists of GPR84 and participates in an expanded polyamine pathway.Dudkina N, Park HB, Song D, Jain A, Khan SA, Flavell RA, Johnson CH, Palm NW, Crawford JM. Cell Chem Biol. 2024 Aug 9; 2024 Aug 9. PMID: 39163853.
• THE ASSOCIATION OF ANEMIA WITH SURVIVAL AMONG PEOPLE WITH HIV FOLLOWING ANTIRETROVIRAL INITIATION IN THE NA-ACCORD 2007-2016.Lang R, Coburn SB, Gill MJ, Grossman J, Gebo KA, Horberg MA, Mayor AM, Justice AC, Bosch RJ, Silverberg MJ, Rabkin CS, Sterling TR, Thorne JE, Moore RD, Althoff KN. J Acquir Immune Defic Syndr. 2024 Aug 9; 2024 Aug 9. PMID: 39118208.
• Exercise and nutrition to improve cancer Treatment-Related outcomes (ENICTO).Schmitz KH, Brown JC, Irwin ML, Robien K, Scott JM, Berger NA, Caan B, Cercek A, Crane TE, Evans SR, Ligibel JA, Meyerhardt JA, Agurs-Collins T, Basen-Engquist K, Bea JW, Cai SF, Cartmel B, Chinchilli VM, Demark-Wahnefried W, Dieli-Conwright CM, DiPietro L, Doerksen SE, Edelstein SL, Elena J, Evans W, Ferrucci LM, Foldi J, Freylersythe S, Furberg H, Jones LW, Levine R, Moskowitz CS, Owusu C, Penedo F, Rabin BA, Ratner E, Rosenzweig M, Salz T, Sanft T, Schlumbrecht M, Spielmann G, Thomson CA, Tjaden AH, Weiser MR, Yang S, Yu AF, Perna FM. J Natl Cancer Inst. 2024 Aug 8; 2024 Aug 8. PMID: 39118255.
• Evaluation of mean corpuscular volume among anemic people with HIV in North America following ART initiation.Lang R, Coburn SB, Gill MJ, Justice AC, Grossman J, Gebo KA, Horberg MA, Mayor AM, Silverberg MJ, McGinnis KA, Hogan B, Moore RD, Althoff KN. AIDS Res Ther. 2024 Aug 7; 2024 Aug 7. PMID: 39113038.
• Anxiety and fear of cancer recurrence as predictors of subsequent pain interference in early cancer survivorship: Exploring the moderating roles of cognitive and emotional factors.Gnall KE, Emrich M, Magin ZE, Park CL, Bellizzi KM, Sanft T. J Behav Med. 2024 Aug 7; 2024 Aug 7. PMID: 39110352.
• Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study.Ji M, Shih YH, Huber JH, Wang M, Feuer EJ, Etzioni R, Wang SY, Chang SH. Cancer Epidemiol Biomarkers Prev. 2024 Aug 6; 2024 Aug 6. PMID: 39106151.
• Risk of Serious Adverse Gastrointestinal Events with Potassium Binders in Hospitalized Patients: A National Study.Holleck JL, Han L, Skanderson M, Bastian LA, Gunderson CG, Brandt CA, Perkal M, Chang JJ, Akgün KM. J Gen Intern Med. 2024 Aug 5; 2024 Aug 5. PMID: 39103605.
• Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world Setting.Leapman MS, Ho J, Liu Y, Filson C, Zhao X, Hakansson A, Proudfoot JA, Davicioni E, Martin DT, An Y, Seibert TM, Lin DW, Spratt DE, Cooperberg MR, Sprenkle PC, Ross AE. Eur Urol Oncol. 2024 Aug 3; 2024 Aug 3. PMID: 39098389.
• Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma.Fiala MA, Ji M, Shih YH, Huber J, Wang M, Johnson KJ, Gasoyan H, Wang R, Colditz GA, Wang SY, Chang SH. Clin Lymphoma Myeloma Leuk. 2024 Aug 2; 2024 Aug 2. PMID: 39209567.
• Clinician Insights into Effective Components, Delivery Characteristics and Implementation Strategies of Ambulatory Palliative Care for People with Heart Failure: A Qualitative Analysis.Feder S, Iannone L, Lendvai D, Zhan Y, Akgün K, Ersek M, Luhrs C, Allen LA, Bekelman DB, Goldstein N, Kavalieratos D. J Card Fail. 2024 Aug 2; 2024 Aug 2. PMID: 39098653.
• Overcoming Systemic Barriers to Make Patient-Partnered Research a Reality.Venkataraman V, Martin-Giacalone BA, Drake BF, Salmi L, Claus EB, Schuster ALR, Bridges JFP, Lenz HJ, Willman CL, Diehl D, Janeway KA, Mack JW, George S. J Clin Oncol. 2024 Aug 2; 2024 Aug 2. PMID: 39094073.
• Trends in use of intensive care during hospitalizations at the end-of-life among older adults with advanced cancer.Jain S, Long JB, Rao V, Law AC, Walkey AJ, Prsic E, Lindenauer PK, Krumholz HM, Gross CP. J Am Geriatr Soc. 2024 Aug 1; 2024 Aug 1. PMID: 39090970.
• Smoking patterns by birth cohort in Argentina: an age-period-cohort population-based modeling study.Salgado MV, Mok Y, Jeon J, Jaffri M, Tam J, Holford TR, Sánchez-Romero LM, Meza R, Mejia R. Lancet Reg Health Am. 2024 Aug; 2024 Jun 21. PMID: 39006127.
• Body image, self-efficacy, and sleep quality among patients with breast cancer: A latent profile and mediation analysis.Li S, Xiang Y, Li H, Yang C, He W, Wu J, Knobf MT, Ye Z. Eur J Oncol Nurs. 2024 Aug; 2024 Jun 27. PMID: 38968669.
• Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Lo Re V 3rd. JAMA Intern Med. 2024 Aug 1. PMID: 38913369.
• Effects of exercise or metformin on myokine concentrations in patients with breast and colorectal cancer: A phase II multi-centre factorial randomized trial.Brown JC, Spielmann G, Yang S, Compton SLE, Jones LW, Irwin ML, Ligibel JA, Meyerhardt JA. J Cachexia Sarcopenia Muscle. 2024 Aug; 2024 Jun 18. PMID: 38887915.
• Health correlates of experiential and behavioral avoidance among trauma-exposed veterans.Schwartz EKC, Palmisano AN, Petrakis IL, Pietrzak RH, Sofuoglu M. J Psychiatr Res. 2024 Aug; 2024 Jun 11. PMID: 38878649.
• Sex differences in appeal, reward, and sensory experience of E-cigarette flavors among adults who smoke cigarettes.Davis DR, Buta E, Green B, Krishnan-Sarin S. Prev Med. 2024 Aug; 2024 Jun 11. PMID: 38866212.
• Progress in Lung Cancer Screening Adoption.Richman IB, Gross CP. JAMA Intern Med. 2024 Aug 1. PMID: 38857025.
• Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink.Denoble AE, Vazquez-Benitez G, Sheth SS, Ackerman-Banks CM, DeSilva MB, Zhu J, Daley MF, Getahun D, Klein NP, Vesco KK, Irving SA, Nelson J, Williams JTB, Hambidge SJ, Donahue JG, Weintraub ES, Kharbanda EO, Lipkind HS. Obstet Gynecol. 2024 Aug 1; 2024 Jun 6. PMID: 38843526.
• Liver epigenomic signature associated with chronic oxidative stress in a mouse model of glutathione deficiency.Hong SH, Yu X, Zhu Y, Chen Y. Chem Biol Interact. 2024 Aug 1; 2024 Jun 1. PMID: 38830566.
• Self-injurious unnatural death among Veterans with HIV.Smith AC, Goulet JL, Vlahov D, Justice AC, Womack JA. AIDS. 2024 Aug 1; 2024 May 28. PMID: 38814683.
• Varenicline for E-Cigarette Cessation in Adults: A Preliminary Placebo-Controlled Randomized Trial.Fucito LM, Baldassarri SR, Baker NL, Palmer AM, O'Malley SS, Carpenter MJ, Krishnan-Sarin S, Gray KM, Toll BA. Am J Prev Med. 2024 Aug; 2024 May 16. PMID: 38752949.
• Time for a Focus on Cessation of E-Cigarettes.Krishnan-Sarin S, Fucito LM. JAMA Intern Med. 2024 Aug 1. PMID: 38709519.
• Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas.Demirkiran C, Greenman M, Bellone S, McNamara B, Hartwich TMP, Manavella D, Mutlu L, Zipponi M, Yang-Hartwich Y, Yang K, Ratner E, Schwartz PE, Coma S, Pachter J, Santin AD. Gynecol Oncol. 2024 Aug; 2024 May 3. PMID: 38703673.
• Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study.Sedrak MS, Sun CL, Bae M, Freedman RA, Magnuson A, O'Connor T, Moy B, Wildes TM, Klepin HD, Chapman AE, Tew WP, Dotan E, Fenton MA, Kim H, Katheria V, Muss HB, Cohen HJ, Gross CP, Ji J. J Cancer Surviv. 2024 Aug; 2024 Apr 28. PMID: 38678525.
• Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia.Bewersdorf JP, Patel KK, Shallis RM, Podoltsev NA, Kewan T, Stempel J, Mendez L, Stahl M, Stein EM, Huntington SF, Goshua G, Zeidan AM. Leuk Lymphoma. 2024 Aug; 2024 Apr 22. PMID: 38648559.
• Identifying Opportunities to Deliver High-Quality Cancer Care Across a Health System: A Clinical Responsibility.Shah HP, Cohen O, Bourdillon AT, Burtness BA, Boffa DJ, Young M, Judson BL, Mehra S. Otolaryngol Head Neck Surg. 2024 Aug; 2024 Apr 12. PMID: 38606669.